<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03667339</url>
  </required_header>
  <id_info>
    <org_study_id>35RC17_3084_AHVACA</org_study_id>
    <nct_id>NCT03667339</nct_id>
  </id_info>
  <brief_title>Direct Anterior Total Hip Arthroplasty (THA), in Versus Outpatients : A Prospective Monocentric Study in Rennes University Hospital.</brief_title>
  <acronym>AHVACA</acronym>
  <official_title>Direct Anterior Total Hip Arthroplasty (THA), in Versus Outpatients : A Prospective Monocentric Study in Rennes University Hospital.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective is to show that cumulative length of stay over the first 45 post operative
      days (i.e. : primary length of stay and readmission) is significantly lower in the
      outpatients group than in the inpatients group
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 27, 2018</start_date>
  <completion_date type="Anticipated">July 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 27, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative lenght of stay</measure>
    <time_frame>45 days before surgery</time_frame>
    <description>Cumulative lenght of stay ( ie : the sum of the days of hospitalization corresponding to the initial hospitalization and readmissions if there are any)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">54</enrollment>
  <condition>Direct Anterior Total Hip Arthroplasty</condition>
  <arm_group>
    <arm_group_label>outpatients group</arm_group_label>
    <description>Patient schedulded to undergo outpatient Direct Anterior Total Hip Arthroplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>inpatients group</arm_group_label>
    <description>Patient schedulded to undergo inpatient Direct Anterior Total Hip Arthroplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Direct Anterior Total Hip Arthroplasty</intervention_name>
    <description>Direct Anterior Total Hip Arthroplasty</description>
    <arm_group_label>inpatients group</arm_group_label>
    <arm_group_label>outpatients group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with Direct Anterior Total Hip Arthroplasty
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Unilateral primary total hip arthroplasty for hip osteoarthritis, primary or secondary
             osteoarthritis (dysplasia or post-traumatic) or osteonecrosis

          -  Good enough understanding of outpatient management and patient adherence to
             post-operative instructions

          -  Sufficient patient complicance to medical orders

          -  Living and hygiene conditions, at least, equivalent to the ones the hospital provides

          -  To be of age

          -  Non opposition to the protocole participation

        Outpatients group :

        - Patient schedulded to undergo outpatient THA

        Inpatients group :

        - Patient schedulded to undergo inpatient THA because of not fiting the following items :

          -  Less than an hour distance of a Health Center that provides appropriate care with
             regard to the surgery

          -  Rapid access to a phone

          -  Designated driver and caretaker available (at least the first night after discharge
             from the hospital) after the procedure Or turning down outpatient THA

        Exclusion Criteria:

          -  Anaesthetic point of view :

               -  ASA physical status ≥ 3 and : unstabilize disease with appropriate treatment or
                  lack of preoperative mutual agreement between anesthesiologist and surgeon or not
                  inconsiderable interaction between the operation and the disease or its treatment

               -  Pre-operative Hb &lt; 12 (♀) &lt; 13 (♂) g/L (NB : no Hb control before discharge
                  except if excessive blood loss ; Hb &lt; 10g/L contraindicates outpatient surgery)

               -  Opioid chronic pre-operative therapy or opioid addiction

          -  Surgical point of view :

               -  Ambulatory pre-operative status requiring use of two crutches or walking frame /
                  distance walked &lt; 30 m

               -  THA procedure for femoral neck fracture requiring

               -  Additional operative technic needed

          -  Adult safeguarding.

        Exclusion criteria applies to all in and outpatients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Jean Louis POLARD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristell COAT</last_name>
    <phone>2 99 28 91 91</phone>
    <phone_ext>+33</phone_ext>
    <email>kristell.coat@chu-rennes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Direction de la Recherche</last_name>
    <phone>2 99 28 25 55</phone>
    <phone_ext>+ 33</phone_ext>
    <email>drc@chu-rennes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35 033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Louis POLARD, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Charlotte CRAMPET</last_name>
    </contact_backup>
    <investigator>
      <last_name>Jean-Louis POLARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charlotte CRAMPET</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 10, 2018</study_first_submitted>
  <study_first_submitted_qc>September 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 12, 2018</study_first_posted>
  <last_update_submitted>September 11, 2018</last_update_submitted>
  <last_update_submitted_qc>September 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

